For BD-related neurologic disease including manifestation such as meningitis and myelitis and not specifically NBrIHwCVT, Tocilizumab has been described to be an effective alternative to conventional treatment options e.g. anti-TNF agents [8, 9]. This evidence concerns the gene TNF and Behcet disease.